Your email has been successfully added to our mailing list.

×
-0.0167808219178082 0.0205479452054795 0.0958904109589042 0.121575342465754 0.246780821917808 0.229452054794521 0.242157534246575 0.164383561643836
Stock impact report

BioAffinity Shares Rise 44% on Lung Cancer Test Study Data [MarketWatch]

bioAffinity Technologies, Inc. (BIAF) 
Company Research Source: MarketWatch
clinical trial studying CyPath Lung, its non-invasive early-stage lung cancer diagnostic test. The San Antonio, Texas, company said the CyPath Lung trial showed 92% sensitivity and 87% specificity in high-risk lung cancer patients who had nodules smaller than 20 millimeters or who didn't have any nodules. Overall, CyPath Lung resulted in testing specificity of 88% and sensitivity of 82%, similar to far more invasive procedures currently used to diagnose lung cancer, BioAffinity said. BioAffinity said CyPath Lung detected multiple forms of lung cancer, including adenocarcinoma, squamous cell carcinoma and small-cell lung cancer. CyPath Lung uses flow cytometry and automated analysis to identify and analyze parameters in lung sputum and whole-cell populations in lung micro-environments which indicate the presence of cancer. BioAffinity shares closed Monday up 5% and are down 10% over the past three months. Write to Chris Wack at chris.wack@wsj.com Show less Read more
Impact Snapshot
Event Time:
BIAF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
BIAF alerts

from News Quantified
Opt-in for
BIAF alerts

from News Quantified